|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 13, 2017 ) Middle East and Africa Multiple Myeloma Therapeutics Market is projected to reach USD 0.82 Billion by 2021, at a CAGR of 4.74% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/middle-east-and-africa-multiple-myeloma-therapeutics-market-863/
Multiple myeloma (MM) is a malignant plasma cell disorder that accounts for almost 10% of all hematologic cancers. Immunotherapy is the latest methodology to multiple myeloma treatment. It is an umbrella term that defines different ways to inspire the immune system and improve its capability to attack cancer cells. Chemicals are released by multiplying myeloma plasma cells that consequence in dissolving and damaging of bones.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-multiple-myeloma-therapeutics-market-863/request-sample
Factors such as varied therapeutic areas, rising investment in research and development for new therapies, increasing demand and extensive off-label use of IG are some of the foremost factors contributing to the growth of the multiple myeloma therapeutics market.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-multiple-myeloma-therapeutics-market-863/inquire
Segmentation:
By Treatment Type:
Chemotherapy
Anthracycline antibiotic
Melphalan (Alkeran)
Liposomal doxorubicin (Doxil)
Alkylating agent
Doxorubicin (Adriamycin)
Cyclophosphamide (Neosar)
Vincristine (Oncovin)
Carmustine (BiCNU)
Targeted therapy
Proteasome inhibitor
Bortezomib (Velcade)
Carfilzomib (Kyprolis)
By Drug Type
Corticosteroids
Dexamethasone (Decadron)
Prednisone (Deltasone/Orasone)
Immunomodulatory agents
Thalidomide (Thalomid)
Lenalidomide (Revlimid)
Arsenic trioxide (Trisenox)
Plerixafor (Mozobil)
By Region
Middle East
Africa
Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC., ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
Buy now http://www.marketdataforecast.com/cart/buy-now/middle-east-and-africa-multiple-myeloma-therapeutics-market-863
The Middle East and Africa Multiple Myeloma Therapeutics Market Study covers:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
Middle East and Africa Radiotherapy Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/middle-east-and-africa-radiotherapy-market-820/
Middle East and Africa Autoimmune Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-autoimmune-monoclonal-antibodies-1175/
Middle East and Africa Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-monoclonal-antibodies-market-1204/
Middle East and Africa Neurotherapeutics Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/middle-east-and-africa-neurotherapeutics-market-1275/
Middle East and Africa Melanoma Therapeutics Market: http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/market-reports/middle-east-and-africa-melanoma-therapeutics-market-856/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
